MedAugmentTM

Is Augmented Reality Marrying Health Literacy, at First Sight?

MedAugment - by Nissen, L., Ahmadvand, A., et al. 1

Alireza Ahmadvand, MDGeneral Practitioner and Research Scholar

School of Clinical SciencesFaculty of Health

Queensland University of Technology (QUT)

Partnership

QU

T • School of Clinical Sciences

• QUT Business School

• Creative Industries

• Digital Media Research Centre

• School of Psychology and Social Work

• QUT Library

Terr

y W

hit

e C

hem

mar

t • Business Development Management

NP

S M

edic

ineW

ise • Executive

Management - Client Relations

Dia

bet

es Q

uee

nsl

and • Research

Office

• Diabetes Education

Pri

nce

ss A

lexa

nd

ra H

osp

ital • Diabetes

Education

Act

ivat

e En

tert

ain

men

t • Director

MedAugment - by Nissen, L., Ahmadvand, A., et al. 2

Team

QUTLisa Nissen (Leader)

Alireza Ahmadvand

Judy Drennan

Jean Burgess

Michele Clark

David Kavanagh

Kara Burns

Sarah Howard

Kaitlyn Porter

PartnersTerry White Chemmart Pharmacy GroupChris Campbell

NPS MedicineWiseKaren Kaye

Diabetes QueenslandFleur Kelly

Princess Alexandra HospitalKerry Porter

Activate EntertainmentTyronne Curtis

MedAugment - by Nissen, L., Ahmadvand, A., et al. 3

Population of interest

MedAugment - by Nissen, L., Ahmadvand, A., et al. 4

~370 million people

all around the world

Potential members of the multidisciplinary diabetes care teams

Many of them are prescribers

The average number of medications being taken: 15 (median: 14) (USA)

Multiple episodes of information exchange (sometimes conflicting pieces of information)

Health literacy affects understanding, choice, and voice, for optimal management

MedAugment - by Nissen, L., Ahmadvand, A., et al. 5

Problem(s) that we are hoping to solve

Limited access to easy-to-understand information at the point of use/purchase

Static nature of consumer medicine information

MedAugment - by Nissen, L., Ahmadvand, A., et al. 6

Sketch of the conceptual solution

MedAugment - by Nissen, L., Ahmadvand, A., et al. 7

Photo Credit: Kara Burns

Demo

MedAugment - by Nissen, L., Ahmadvand, A., et al. 8

A new spectrum of care

January February March April May June July August September October November December

MedAugment - by Nissen, L., Ahmadvand, A., et al. 9

Alignment with ATC 2017 theme

MedAugment - by Nissen, L., Ahmadvand, A., et al. 10

Questions to be answered

• How should a new augmented reality solution be developed and designed for improving health literacy and medication safety in type 2 DM?

• Is the new AR solution feasible for improving health literacy and changing behaviour of people living with type 2 DM?

• Is the new AR solution acceptable to consumers and organisations? Are they willing to use/pay for the new solution?

MedAugment - by Nissen, L., Ahmadvand, A., et al. 11

Stage of Development

MedAugment - by Nissen, L., Ahmadvand, A., et al. 12

Secured and Future Funding

MedAugment - by Nissen, L., Ahmadvand, A., et al. 13

Potential Interested Groups

Patients and Carers

Pharmacy Service Providers

Community/Non-governmental Organisations

Pharmaceutical Companies

Developers (content and

tech)

Mobile Network Operators

MedAugment - by Nissen, L., Ahmadvand, A., et al. 14

Challenges and Strategies

Challenges

• Concept development based on known gaps

• Team building

• Funding

Strategies

• Build multidisciplinary teams and sub-teams

• Applying for similar funding opportunities and schemes

MedAugment - by Nissen, L., Ahmadvand, A., et al. 15

Future directions

• Expanding the coverage of the solution• Pharmaceutical products

• Healthcare and beauty products

• Commercialisation• Licensing

• Investment

• Technical evolution• Genericisation

MedAugment - by Nissen, L., Ahmadvand, A., et al. 16

Thank you!

MedAugment - by Nissen, L., Ahmadvand, A., et al. 17